BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20976738)

  • 21. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Zibetti M; Merola A; Rizzi L; Ricchi V; Angrisano S; Azzaro C; Artusi CA; Arduino N; Marchisio A; Lanotte M; Rizzone M; Lopiano L
    Mov Disord; 2011 Nov; 26(13):2327-34. PubMed ID: 22012750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.
    Volkmann J; Albanese A; Kulisevsky J; Tornqvist AL; Houeto JL; Pidoux B; Bonnet AM; Mendes A; Benabid AL; Fraix V; Van Blercom N; Xie J; Obeso J; Rodriguez-Oroz MC; Guridi J; Schnitzler A; Timmermann L; Gironell AA; Molet J; Pascual-Sedano B; Rehncrona S; Moro E; Lang AC; Lozano AM; Bentivoglio AR; Scerrati M; Contarino MF; Romito L; Janssens M; Agid Y
    Mov Disord; 2009 Jun; 24(8):1154-61. PubMed ID: 19412954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mood stability during acute stimulator challenge in Parkinson's disease patients under long-term treatment with subthalamic deep brain stimulation.
    Berney A; Panisset M; Sadikot AF; Ptito A; Dagher A; Fraraccio M; Savard G; Pell M; Benkelfat C
    Mov Disord; 2007 Jun; 22(8):1093-6. PubMed ID: 17394245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
    Pinto S; Gentil M; Fraix V; Benabid AL; Pollak P
    J Neurol; 2003 Feb; 250(2):179-87. PubMed ID: 12574948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
    Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.
    Alegret M; Valldeoriola F; Martí M; Pilleri M; Junqué C; Rumià J; Tolosa E
    Mov Disord; 2004 Dec; 19(12):1463-9. PubMed ID: 15390065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
    Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
    Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
    Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
    Lyons KE; Davis JT; Pahwa R
    Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
    Erola T; Heikkinen ER; Haapaniemi T; Tuominen J; Juolasmaa A; Myllylä VV
    Acta Neurochir (Wien); 2006 Apr; 148(4):389-94. PubMed ID: 16284705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic stimulation of the subthalamic nucleus increases daily on-time without dyskinesia in advanced Parkinson's disease.
    Portman AT; van Laar T; Staal MJ; Rutgers AW; Journee HL; Leenders KL
    Parkinsonism Relat Disord; 2006 Apr; 12(3):143-8. PubMed ID: 16460986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive change on the repeatable battery of neuropsychological status (RBANS) in Parkinson's disease with and without bilateral subthalamic nucleus deep brain stimulation surgery.
    Rinehardt E; Duff K; Schoenberg M; Mattingly M; Bharucha K; Scott J
    Clin Neuropsychol; 2010 Nov; 24(8):1339-54. PubMed ID: 20967688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus.
    Schüpbach MW; Welter ML; Bonnet AM; Elbaz A; Grossardt BR; Mesnage V; Houeto JL; Maltête D; Mallet L; Rocca WA; Mallet A; Agid Y
    Mov Disord; 2007 Jan; 22(2):257-61. PubMed ID: 17149702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
    Alvarez L; Macias R; Lopez G; Alvarez E; Pavon N; Rodriguez-Oroz MC; Juncos JL; Maragoto C; Guridi J; Litvan I; Tolosa ES; Koller W; Vitek J; DeLong MR; Obeso JA
    Brain; 2005 Mar; 128(Pt 3):570-83. PubMed ID: 15689366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The value of the internal capsule signs in the stimulation of the subthalamic nucleus in Parkinson's disease].
    Escamilla F; Mínguez A; Jouma-Katati M; Meersmans Sánchez-Jofré M; Arnáiz-Urrutia C; Martín-Linares JM; Ortega-Moreno A; Arjona-Morón V
    Rev Neurol; 2005 Aug 16-31; 41(4):193-7. PubMed ID: 16075395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suicide attempts after subthalamic nucleus stimulation for Parkinson's disease.
    Rodrigues AM; Rosas MJ; Gago MF; Sousa C; Fonseca R; Linhares P; Basto MA; Sousa G; Garrett C; Vaz R
    Eur Neurol; 2010; 63(3):176-9. PubMed ID: 20197662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.